Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AB Soars 46% as Cancer Drug Beats Pfizer’s Sutent: Paris Mover
AB Soars 46% as Cancer Drug Beats Pfizer’s Sutent: Paris Mover
AB Soars 46% as Cancer Drug Beats Pfizer’s Sutent: Paris Mover
Submitted by
admin
on February 2, 2012 - 9:15am
Source:
Bloomberg
News Tags:
Pfizer
Sutent
AB Science
masitinib
gastrointestinal cancer
Headline:
AB Soars 46% as Cancer Drug Beats Pfizer’s Sutent: Paris Mover
Do Not Allow Advertisers to Use My Personal information
